Cite
HARVARD Citation
Lessem, E. et al. (2017). Bedaquiline or delamanid for rifampin-resistant tuberculosis?. Lancet. 5 (10), pp. 772-774. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lessem, E. et al. (2017). Bedaquiline or delamanid for rifampin-resistant tuberculosis?. Lancet. 5 (10), pp. 772-774. [Online].